Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice (Q40622821)

22 September 2017

Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice (English)

1 reference

22 September 2017

0 references

Kelly EP

1

1 reference

22 September 2017

Greene JJ

series ordinal

2

1 reference

22 September 2017

King AD

series ordinal

3

1 reference

22 September 2017

Innis BL

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

22 September 2017

1 reference

22 September 2017

18

1 reference

22 September 2017

23

1 reference

22 September 2017

2549-2559

1 reference

Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Pathogenesis of dengue: challenges to molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Antibody-enhanced dengue virus infection in primate leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Characterization of immune responses to experimental polyvalent subunit vaccines assembled in iscoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Production and characterization of arbovirus antibody in mouse ascitic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Expression of the major capsid protein VP6 of group C rotavirus and synthesis of chimeric single-shelled particles by using recombinant baculoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Synthesis of viruslike particles by expression of the putative capsid protein of Leishmania RNA virus in a recombinant baculovirus expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Hepatitis B virus surface antigen (HBsAg) as carrier for synthetic peptides having an attached hydrophobic tail

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900032-3

7 January 2021

10.1016/S0264-410X(00)00032-3

Identifiers

DOI

1 reference

22 September 2017

1 reference